ArticleScientific reports2025
Longitudinal assessment of tricuspid regurgitation following conduction system pacing.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incidence and Predictors of Acute Tricuspid Regurgitation Worsening After Left Bundle Branch Area Pacing.Circulation reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tricuspid regurgitation (TR) is a well-known complication of pacemaker implantation (PMI). Recently, the conduction system pacing (CSP) technique, which could avoid the development of ventricular dyssynchrony, was established. However, the impact of CSP on TR is unclear. This study aimed to describe the association between CSP and worsening TR. The data of 110 patients who were given a transthoracic echocardiogram (TTE) before and after PMI were retrospectively analyzed. The severity of TR was classified into four groups. Worsening TR was defined as one or more grade increases in TR. Twenty (18.2%) patients had worsening TR, and 7 patients (6.4%) had TR ≥ moderate after PMI. After comparing the patients with and without CSP, 5 (27.8%) and 15 (16.3%) patients, respectively, had worsening TR, but the frequency did not indicate a significant difference (P = 0.25). The frequency of TR ≥ moderate after PMI in the former group was significantly higher than in the latter group at 3 (16.7%) and 4 (4.3%), respectively (P = 0.05). This study revealed that patients with CSP had a higher frequency of TR ≥ moderate after PMI compared to patients without CSP in the medium term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.